IVF市場規模、佔有率、成長分析（按產品類型、按產品、按類型、按設備、按最終用戶、按地區）- 產業預測 2025-2032

2023 年 IVF 市場規模價值為 268 億美元，預計將從 2024 年的 290.5 億美元成長到 2032 年的 553.9 億美元，預測期內（2025-2032 年）的複合年成長率為 8.4%。

全球體外受精（IVF）市場（包括輔助生殖技術）作為解決不孕症問題的方法已獲得顯著發展，使夫妻能夠透過體外受精過程受孕。由於生活方式的改變、受孕延遲和各種健康狀況導致不孕不育率上升，試管受精為那些面臨自然受孕挑戰的人們帶來了希望。持續的技術進步，包括改進的實驗室技術、基因檢測和改進的胚胎選擇，正在提高成功率並吸引尋求可靠不孕症解決方案的夫妻。體外受精 (IVF) 的需求正在快速成長，尤其是在新興市場，人們的意識和可及性的提高推動了市場的成長。儘管這種治療存在精神和身體上的障礙，但新的技術創新和改善的患者體驗為 IVF 領域的擴展帶來了良好的機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析

IVF 市場規模（依產品類型及複合年成長率）(2025-2032)

• 市場概覽
• 新捐款者
• 新的非捐贈者
• 凍結捐贈者
• 冷凍非捐贈者

體外受精市場規模：依產品及複合年成長率（2025-2032）

• 市場概覽
• 裝置
  • 精子分析系統
  • 影像系統
  • 卵子吸泵
  • 微作業系統
  • 培養箱
  • 氣體分析儀
  • 雷射系統
  • 低溫系統
  • 精子分離裝置
  • 試管嬰兒櫃
  • 防震台
  • 證人制度
  • 其他設備
• 試劑和培養基
  • 冷凍保存液
  • 胚胎培養基
  • 卵子處理介質
  • 精子處理培養基
• 配件

IVF 市場規模（按類型及複合年成長率）(2025-2032)

• 市場概覽
• 傳統試管嬰兒
• 體外受精及顯微授精
• 捐卵子試管嬰兒
• 其他

體外受精市場規模：依設備及複合年成長率（2025-2032）

• 市場概覽
• 文化傳媒
• 免洗設備
• 資本設備

IVF 市場規模（依最終用戶和複合年成長率）(2025-2032)

• 市場概覽
• 不孕不育診所
• 手術中心
• 醫院
• 研究機構

體外受精市場規模：依地區及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Ferring Pharmaceuticals（Switzerland）
• Merck KGaA（Germany）
• Cook Medical（USA）
• Vitrolife AB（Sweden）
• CooperSurgical, Inc.（USA）
• Ovascience, Inc.（USA）
• Irvine Scientific（USA）
• Genea Limited（Australia）
• Origio A/S（Denmark）
• Thermo Fisher Scientific Inc.（USA）
• Esco Medical ApS（Denmark）
• Nidacon International AB（Sweden）
• Boston IVF（USA）
• Virtus Health（Australia）
• Bloom Fertility Centre（India）
• Rainbow IVF（India）
• IVI RMA Global（Spain）
• CHA Healthcare（South Korea）
• Reproductive Medicine Associates of New Jersey（RMANJ）（USA）
• TSLC Corporation（Japan）

結論和建議

In Vitro Fertilization Market size was valued at USD 26.8 billion in 2023 and is poised to grow from USD 29.05 billion in 2024 to USD 55.39 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global In Vitro Fertilization (IVF) market, encompassing assisted reproductive technologies, has gained significant traction as a solution for infertility, enabling couples to conceive through external fertilization processes. With rising infertility rates attributed to lifestyle changes, late pregnancies, and various health conditions, IVF offers hope to those facing challenges in natural conception. Continuous technological advancements, including enhanced laboratory techniques, genetic testing, and improved embryo selection, have boosted success rates, attracting more couples seeking reliable fertility solutions. The demand for IVF is particularly surging in developing regions, where increased awareness and access are driving market growth. Despite the emotional and physical hurdles associated with the treatment, emerging innovations and improving patient experiences present promising opportunities for expansion in the IVF sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

In Vitro Fertilization Market Segments Analysis

Global In Vitro Fertilization Market is segmented by Product Type, Product, Type, Instrument, End User and region. Based on Product Type, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor and Frozen Non-Donor. Based on Product, the market is segmented into Equipment, Reagents & Media and Accessories. Based on Type, the market is segmented into Conventional IVF, IVF with ICSI, IVF with Donar Eggs and Others. Based on Instrument, the market is segmented into Culture Media, Disposable Devices and Capital Equipment. Based on End User, the market is segmented into Fertility Clinics, Surgical Centers, Hospitals and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the In Vitro Fertilization Market

The In Vitro Fertilization (IVF) market has experienced considerable growth due to remarkable advancements in reproductive technologies observed in 2021. Notably, the implementation of time-lapse imaging systems revolutionized the monitoring process for embryo development by enabling continuous observation. This innovation facilitated better selection of embryos, ultimately resulting in enhanced success rates for IVF procedures. As a result, these technological improvements have encouraged an increasing number of individuals and couples to pursue IVF treatments, thereby driving the overall demand and expansion of the IVF market in recent years.

Restraints in the In Vitro Fertilization Market

The financial burden of In Vitro Fertilization (IVF) treatments has been a considerable constraint, particularly noted in 2021. The high costs associated with medication, laboratory procedures, and the need for several treatment cycles can be overwhelming. This significant expense often renders IVF unattainable for many individuals and couples, especially those lacking sufficient financial means or insurance coverage. As a result, the affordability of these essential reproductive services remains a major barrier, limiting access for those who might benefit from such treatments and hindering their ability to pursue family planning options effectively.

Market Trends of the In Vitro Fertilization Market

The In Vitro Fertilization (IVF) market is witnessing a notable trend towards the rising demand for genetic testing, particularly techniques like preimplantation genetic testing (PGT). In 2022, the integration of PGT into IVF procedures gained momentum as more couples sought to enhance their chances of successful pregnancies while minimizing the risk of genetic disorders in their future children. This shift is driven by increased awareness of genetic health and advancements in testing technologies, making it a critical factor in reproductive planning. As a result, IVF clinics are increasingly adopting these innovative genetic testing methods, reflecting a broader market trend that favors personalized and health-conscious fertility solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global In Vitro Fertilization Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor

Global In Vitro Fertilization Market Size by Product & CAGR (2025-2032)

• Market Overview
• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other Equipments
• Reagents & Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Accessories

Global In Vitro Fertilization Market Size by Type & CAGR (2025-2032)

• Market Overview
• Conventional IVF
• IVF with ICSI
• IVF with Donar Eggs
• Others

Global In Vitro Fertilization Market Size by Instrument & CAGR (2025-2032)

• Market Overview
• Culture Media
• Disposable Devices
• Capital Equipment

Global In Vitro Fertilization Market Size by End User & CAGR (2025-2032)

• Market Overview
• Fertility Clinics
• Surgical Centers
• Hospitals
• Research Institutes

Global In Vitro Fertilization Market Size & CAGR (2025-2032)

• North America (Product Type, Product, Type, Instrument, End User)
  • US
  • Canada
• Europe (Product Type, Product, Type, Instrument, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Product, Type, Instrument, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Product, Type, Instrument, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Product, Type, Instrument, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ovascience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Irvine Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Origio A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidacon International AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston IVF (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virtus Health (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloom Fertility Centre (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rainbow IVF (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVI RMA Global (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CHA Healthcare (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reproductive Medicine Associates of New Jersey (RMANJ) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TSLC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations